Panniculitis in Anti-MDA-5 Positive Juvenile Dermatomyositis: A Case Report. [PDF]
JNMA J Nepal Med AssocPanniculitis is a rare clinical finding in dermatomyositis. There are few reported cases in the medical literature. In this report, we describe a 17-year-old male patient with anti-MDA5 positive hypomyopathic dermatomyositis who, eight months after ...
Ayduran S +5 more
europepmc +2 more sources
Revista Brasileira de Reumatologia, 2012 OBJETIVO: Avaliar a capilaroscopia periungueal de crianças e adolescentes com doenças reumáticas autoimunes (artrite idiopática juvenil, lúpus eritematoso sistêmico, dermatomiosite juvenil, esclerodermia e doença mista do tecido conjuntivo) e relacioná ...
Daniela Gerent Petry Piotto +3 more
doaj +1 more source
Juvenile dermatomyositis with vasculopathy
, 2022 Juvenile dermatomyositis (JDM) is rare, but serious disease with many possible complications. Hallmarks of this disease are heliotrope erythema, periorbital edema and Gottrone papules combined with symmetric proximal muscle weakness that usually slowly ...
Kovačević, Mia +2 more
core +1 more source
First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome
Reumatismo, 2017 Inflammatory myopathies as para-neoplastic phenomena were first described by Sterz in 1916. Recently, myositis specific autoantibodies were described in cancer-associated myositis.
B. Palterer, G. Vitiello, D. Cammelli
doaj +1 more source
Dermatomyositis Associated with Celiac Disease: Response to a Gluten-Free Diet
Canadian Journal of Gastroenterology, 2006 The association between dermatomyositis and celiac disease in children has been well documented. In the adult population, however, the association has not been clearly established.
Min Soo Song +5 more
doaj +1 more source
Efficacy and Safety of Cyclophosphamide Treatment in Severe Juvenile Dermatomyositis Shown by Marginal Structural Modeling [PDF]
, 2018 OBJECTIVE: In patients with severe or refractory juvenile dermatomyositis (JDM), second-line treatments may be required. Cyclophosphamide (CYC) is used to treat some connective tissue diseases, but evidence of efficacy in JDM is limited. This study aimed
Simou, S +7 more
core
Intramural ureteric calcification in dermatomyositis mimicking pelviureteric junction obstruction
Journal of Indian Association of Pediatric Surgeons, 2005 Juvenile dermatomyositis classically manifests as necrotising vasculitis in multiple organs. It mainly involves the vessels of skin and muscle and is associated with subcutaneous deposits of calcium.
Shah Amar, Thakur Rakesh, Parashar Karan
doaj
Analysis of Published Criteria for Clinically Inactive Disease in a Large Juvenile Dermatomyositis Cohort Shows That Skin Disease Is Underestimated [PDF]
, 2015 The Pediatric Rheumatology International Trials Organisation (PRINTO) recently published criteria for classification of patients with juvenile dermatomyositis (DM) as having clinically inactive disease.
Lucy R. Wedderburn +12 more
core +1 more source
Cricoarytenoid joint arthritis: a possible complication of dermatomyositis
The Pan African Medical Journal, 2020 Cricoarytenoid joint arthritis is most frequently reported in Rheumatoid Arthritis and in other systemic diseases such as Sjogren´s syndrome, Systemic Lupus Erythematosus, Ankylosing Arthritis, Juvenile Chronic Arthritis, and autoimmune hepatitis but it ...
Chadi Farah +4 more
doaj +1 more source
Juvenile Dermatomyositis Forty Years On: Case Report
, 2018 We present a case report of a 42 year old female, diagnosed at the age of 3 with Juvenile Dermatomyositis. The clinical course was severe and refractory to immunosuppressive therapy. Currently, she is mostly affected by severe muscle atrophy, large joint
Silva Nunes, J +5 more
core +1 more source